Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Product type
Topic
- Advertising (274)
- COVID-19 (163)
- Safety monitoring and information (99)
- Legislation (93)
- Compliance and enforcement (67)
- Vaping hub (53)
- Manufacturing (52)
- Labelling and packaging (35)
- Scheduling (national classification system) (27)
- Import and export (26)
- Medicinal cannabis hub (25)
- Sunscreens (16)
- Shortages and supply disruptions (14)
- Weight loss products (14)
- Committees and advisory bodies (9)
- Cosmetics (5)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Type of content
Search
9 result(s) found, displaying 1 to 9
-
News articlesFollowing our Essential Principles presentations on 11-12 September 2024, we have collated questions asked into themes to simplify finding information of relevance to you.
-
News articlesTo help sponsors and manufacturers transition to new manufacturer evidence.
-
News articlesTransition period for accepting ISO 13485 ends 26 May 2023.
-
News articlesThe TGA will recognise the extended transition for the European Union Medical Device Regulation (EU MDR).
-
Media releasesThe TGA has approved the first two nasal combination self-tests (for use at home) that detect both COVID-19 and influenza viral infections in humans.
-
News articlesOn 28 March 2018, the Senate Community Affairs References Committee reported on its inquiry into the number of women in Australia who have had transvaginal mesh implants and related matters - external site.
-
News articlesInvitation to the National Measurement Institute's mask/respirator testing forum.
-
News articlesChanges will be made to the regulation of nappy rash products on 1 January 2020
-
Regulatory decision noticesTherapeutic Goods Order No. 1 of 2010.